FMS
Fresenius Medical Care Corporation
NYSE: FMS · HEALTHCARE · MEDICAL CARE FACILITIES
$22.16
-1.55% today
Updated 2026-04-29
Market cap
$12.44B
P/E ratio
11.56
P/S ratio
0.63x
EPS (TTM)
$1.97
Dividend yield
3.58%
52W range
$21 – $30
Volume
0.6M
Fresenius Medical Care Corporation (FMS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.44B | $6.67B | $7.62B | $7.85B | $9.06B | $9.87B | $10.43B | $10.58B | $13.02B | $15.31B | $17.03B | $17.78B | $16.55B | $17.48B | $17.86B | $17.62B | $19.40B | $19.45B | $19.34B | $19.63B |
| Revenue growth (YoY) | — | +3.5% | +14.3% | +3.0% | +15.4% | +8.9% | +5.7% | +1.4% | +23.1% | +17.6% | +11.2% | +4.4% | -7.0% | +5.6% | +2.2% | -1.3% | +10.1% | +0.3% | -0.6% | +1.5% |
| Cost of revenue | $4.26B | $4.37B | $5.02B | $5.18B | $5.95B | $6.38B | $6.96B | $7.15B | $8.91B | $10.43B | $11.53B | $11.78B | $11.39B | $12.08B | $12.32B | $12.85B | $14.50B | $14.53B | $14.58B | $14.60B |
| Gross profit | $2.18B | $2.30B | $2.61B | $2.67B | $3.12B | $3.49B | $3.48B | $3.43B | $4.11B | $4.88B | $5.50B | $6.00B | $5.16B | $5.40B | $5.54B | $4.77B | $4.89B | $4.93B | $4.76B | $5.03B |
| Gross margin | 33.9% | 34.5% | 34.2% | 34.1% | 34.4% | 35.3% | 33.3% | 32.4% | 31.6% | 31.8% | 32.3% | 33.8% | 31.2% | 30.9% | 31.0% | 27.1% | 25.2% | 25.3% | 24.6% | 25.6% |
| R&D | $38.86M | $45.63M | $57.64M | $65.48M | $72.58M | $85.51M | $84.41M | $91.11M | $100.33M | $128.05M | $154.04M | $131.00M | $134.00M | $168.03M | $193.77M | $220.78M | $228.62M | $231.97M | $183.49M | $158.00M |
| SG&A | $1.17B | $1.17B | $1.35B | $1.38B | $1.60B | $1.83B | $1.68B | $1.73B | $2.17B | $2.65B | $2.89B | $3.58B | $2.87B | $3.06B | $3.16B | $3.10B | $2.37B | $2.39B | $2.37B | $3.03B |
| Operating income | $998.73M | $1.08B | $1.20B | $1.23B | $1.45B | $1.60B | $1.68B | $1.63B | $1.85B | $2.13B | $2.51B | $2.36B | $3.04B | $2.27B | $2.30B | $1.85B | $1.51B | $1.37B | $1.39B | $1.83B |
| Operating margin | 15.5% | 16.3% | 15.8% | 15.6% | 16.0% | 16.2% | 16.1% | 15.4% | 14.2% | 13.9% | 14.7% | 13.3% | 18.4% | 13.0% | 12.9% | 10.5% | 7.8% | 7.0% | 7.2% | 9.3% |
| EBITDA | $1.20B | $1.33B | $1.52B | $1.56B | $1.84B | $2.08B | $2.14B | $2.13B | $2.50B | $2.80B | $3.04B | $3.00B | $2.91B | $3.92B | $4.13B | $3.55B | $3.42B | $3.21B | $3.21B | $2.96B |
| EBITDA margin | 18.7% | 20.0% | 19.9% | 19.9% | 20.3% | 21.0% | 20.5% | 20.1% | 19.2% | 18.3% | 17.8% | 16.9% | 17.6% | 22.5% | 23.1% | 20.1% | 17.6% | 16.5% | 16.6% | 15.1% |
| EBIT | $968.25M | $1.08B | $1.22B | $1.24B | $1.47B | $1.65B | $1.68B | $1.66B | $1.92B | $2.15B | $2.34B | $2.27B | $2.18B | $2.33B | $2.35B | $1.93B | $1.58B | $1.46B | $1.46B | $1.51B |
| Interest expense | $281.62M | $274.10M | $259.72M | $224.30M | $229.69M | $274.95M | $355.79M | $324.07M | $407.07M | $457.89M | $426.81M | $416.20M | $448.00M | $491.06M | $409.98M | $353.60M | $360.14M | $424.64M | $407.04M | $384.41M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $406.69M | $491.86M | $587.32M | $621.98M | $735.75M | $826.45M | $897.39M | $803.76M | $859.37M | $941.19M | $1.18B | $1.28B | $1.98B | $1.20B | $1.16B | $969.31M | $673.40M | $499.00M | $537.91M | $978.00M |
| Net income growth (YoY) | — | +20.9% | +19.4% | +5.9% | +18.3% | +12.3% | +8.6% | -10.4% | +6.9% | +9.5% | +25.6% | +8.3% | +54.8% | -39.5% | -2.9% | -16.8% | -30.5% | -25.9% | +7.8% | +81.8% |
| Profit margin | 6.3% | 7.4% | 7.7% | 7.9% | 8.1% | 8.4% | 8.6% | 7.6% | 6.6% | 6.1% | 6.9% | 7.2% | 12.0% | 6.9% | 6.5% | 5.5% | 3.5% | 2.6% | 2.8% | 5.0% |